Epocrates to boost mobile healthcare support tools with IPO:
This article was originally published in Clinica
Executive Summary
Epocrates, a developer of mobile decision support software for the healthcare sector, is looking to raise $75m through an IPO on the Nasdaq Stock Exchange. The firm provides healthcare software that doctors can load onto hand-held, electronic point-of-care devices, such as PDAs or smartphones, and use to help in their clinical decision-making to enhance patient safety, comply with clinical standards of care, improve practice productivity, and better manage information. According to Epocrates, 50% of physicians use devices such as PDAs or smartphones in the US. The San Mateo, California-based firm will list under the ticker symbol "EPOC".